Academia
Leverage the world’s largest, up-to-date, longitudinal clinical and claims data to generate real-world evidence.
Bring TriNetX to Your Organization
Research Institute
Utilize real-world data to excel in research. TriNetX is available for department-wide use.
Department Heads
Empower your department with data designed for scientific publications, grant submissions, poster presentations and much more.
Individual Researchers
Download data sets, perform advanced analyses for grant submissions, manuscript and poster submissions, and collaborate with like-minded researchers.
Classroom
Discover the power of data in the classroom; students and educators can iterate quickly using TriNetX, reaching real-time answers without the need for time-intensive statistical platforms.
Teachers
Communicate complex, advanced analyses to students using real data in real time. Provide students with a powerful tool to answer their clinical questions.
Students
Access data for dissertation and manuscript development. Explore EMR and claims data to learn more about target populations, compare drug effectiveness, assess real-world drug performance and much more.
Global Breadth. Unprecedented Depth. All Therapeutic Areas.
Top Therapeutic Areas
Sample Indication Counts
-
1,003 Neuroblastoma (aged <10)
-
2,571 Triple Negative Breast Cancer
-
34,183 Histology Confirmed NSCLC
-
109,412 Crohn’s Disease
-
462,422 Pediatric Asthma
Data Characteristics
Benefits
-
Research-ready EMR data
-
All therapeutic areas
-
Comprehensive pediatric data
-
Inpatient/outpatient
-
Data curated, standardized and mapped to common data models
-
Generate replicable, generalized results
-
Detailed insight into rare diseases
-
Reduce selection bias with data sourced from diverse sites
-
Explore patient cohorts to discover comorbidities and confounders
-
Create your most accurate cohorts using temporal events, disease milestones, and in-depth medication details
Publications Using TriNetX
Masurkar P., Rege S., & Aparasu R.R. (2019) ND4 Comparison Of TriNetX Electronic Medical Record Database And National Ambulatory Medical Care Survey: Findings On The Inappropriate Medications Use In Parkinson’s Disease In The United States. Value in Health, Vol. 22, S43. doi: https://doi.org/10.1016/j.jval.2019.04.062
Buysse B., & Albano J. (2019.) A Snapshot of Characteristics Recorded in Electronic Medical Records of Women with Polycystic Ovary Syndrome in TriNetX Within Two Years of Diagnosis. Syneos Health Morrisville, NC, USA; 2. Syneos Health, Farnborough, UK. 35th ICPE, Philadelphia, PA, 26 Aug 2019
Stacey, J., Lovestone, S., Harrison, P., Denis, M., Nevado-Holgado, A., & Newby, D. (2018). PND2 – Risk of Parkinson’s Disease (PD) in Patients Taking Adrenergic Drug Treatments. Value in Health, Vol. 21, S329. doi: https://doi.org/10.1016/j.jval.2018.09.1969
Martin, C. A., Burgess, D. R., Wallace, K. L., Vanhoose, J., Cotner, S., & Burgess, D. S. (2018). 1026. Trends in Infective Endocarditis During the Substance Use Disorder Epidemic at an Academic Medical Center. Open Forum Infectious Diseases, 5(Suppl 1), S306. doi:10.1093/ofid/ofy210.863
Kolodney, J.A., Kolodney, M., Pattersion, J., Hagen, R., Smolkin, M., Hobbs., G., Hogan, T., Hafex, M., & Albandar, H. (2019). A study of tobacco abuse as a risk factor for adrenal cortical carcinoma. Journal of Clinical Oncology 37, no. 15_suppl. doi:10.1200/JCO.2019.37.15_suppl.e16119
Acharya, M., & Painter, J. (2018). New Oral Anticoagulants And The Risk Of Vasculitis: A Nested Case-Control Study. Value in Health, Vol. 21, S55. doi: https://doi.org/10.1016/j.jval.2018.04.324